BiomX Inc. (PHGE)
NYSEAMERICAN: PHGE · Real-Time Price · USD
0.729
+0.001 (0.07%)
At close: Nov 4, 2024, 4:00 PM
0.710
-0.019 (-2.54%)
After-hours: Nov 4, 2024, 7:42 PM EST
BiomX Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Selling, General & Admin | 10.29 | 9.56 | 10.56 | 12.28 | 9.99 | 8.72 | |
Research & Development | 18.41 | 15.79 | 15.14 | 21.67 | 18.75 | 13.49 | |
Operating Expenses | 28.7 | 25.35 | 27.22 | 35.46 | 30.26 | 22.21 | |
Operating Income | -28.7 | -25.35 | -27.22 | -35.46 | -30.26 | -22.21 | |
Interest Expense | -3.39 | -2.4 | -2.07 | -0.7 | - | - | |
Interest & Investment Income | 0.47 | 1.12 | 0.46 | 0.09 | 0.64 | 0.92 | |
Currency Exchange Gain (Loss) | 0.18 | 0.18 | 0.45 | -0.08 | -0.35 | 0.48 | |
Other Non Operating Income (Expenses) | 4.11 | 0.3 | 0.12 | -0.01 | -0.01 | -0.06 | |
EBT Excluding Unusual Items | -27.34 | -26.15 | -28.25 | -36.16 | -29.97 | -20.87 | |
Other Unusual Items | 1.98 | - | - | - | -0.12 | 0.3 | |
Pretax Income | -26.23 | -26.15 | -28.25 | -36.16 | -30.09 | -20.56 | |
Income Tax Expense | 0.02 | 0.02 | 0.07 | 0.07 | - | - | |
Net Income | -26.25 | -26.17 | -28.32 | -36.23 | -30.09 | -20.56 | |
Net Income to Common | -26.25 | -26.17 | -28.32 | -36.23 | -30.09 | -20.56 | |
Shares Outstanding (Basic) | 6 | 5 | 3 | 3 | 2 | 1 | |
Shares Outstanding (Diluted) | 6 | 5 | 3 | 3 | 2 | 1 | |
Shares Change (YoY) | 76.68% | 71.94% | 14.79% | 12.77% | 310.66% | 180.45% | |
EPS (Basic) | -4.14 | -5.10 | -9.49 | -13.93 | -13.05 | -36.62 | |
EPS (Diluted) | -4.14 | -5.10 | -9.49 | -13.93 | -13.05 | -36.62 | |
Free Cash Flow | -34.81 | -21.34 | -29.2 | -31.26 | -25.46 | -18.89 | |
Free Cash Flow Per Share | -5.49 | -4.16 | -9.78 | -12.02 | -11.04 | -33.64 | |
EBITDA | -27.71 | -24.48 | -26.22 | -34.42 | -29.6 | -21.89 | |
D&A For EBITDA | 0.99 | 0.87 | 1 | 1.05 | 0.66 | 0.32 | |
EBIT | -28.7 | -25.35 | -27.22 | -35.46 | -30.26 | -22.21 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.